Industry Research Reports
Home > Reports > Service & Software > Global Bio-coupling Drug Outsourcing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Bio-coupling Drug Outsourcing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-02-09
Pages: 102 Pages
Report ld: 3679120
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Bio-coupling Drug Outsourcing Services Market Size(US$)
CAGR 2025-2031
18.4%
Market Size,2031
USD 8,725
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,167 million
Market Forecast in 2031(Value)
US$ 8,725 million
CAGR
18.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Bio-coupling Drug Outsourcing Services market size was US$ 2675 million in 2024 and is forecast to a readjusted size of US$ 8725 million by 2031 with a CAGR of 18.4% during the forecast period 2025-2031.
Bio-coupling Drug Outsourcing Services are full-process contract research, development and manufacturing services (CRDMO) for pharmaceutical companies, from drug discovery and development to manufacturing, focusing on the development and production of bioconjugated drugs (such as antibody drug conjugate ADCs). These services involve interdisciplinary expertise, including biologics and small molecule drug coupling technologies, and are designed to help pharmaceutical companies efficiently develop and produce highly effective and cytotoxic cancer drugs.
The North America Bio-coupling Drug Outsourcing Services market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Bio-coupling Drug Outsourcing Services include Lonza, BSP Pharmaceuticals, Catalent, Merck, WuXi XDC Cayman Inc, Thermo Fisher Scientific, Samsung Biologics, Recipharm, Axplora, Sterling Pharmaceuticals、, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Bio-coupling Drug Outsourcing Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bio-coupling Drug Outsourcing Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
By Company
- Lonza
- BSP Pharmaceuticals
- Catalent
- Merck
- WuXi XDC Cayman Inc
- Thermo Fisher Scientific
- Samsung Biologics
- Recipharm
- Axplora
- Sterling Pharmaceuticals、
- NJ Bio, Inc
- Piramal Grangemouth
- Abzena
- Fleet Bioprocessing
- MabPlex international
- Toyo Pharm
- Aobak
- Asymchem
- Porton Pharma Solutions
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Antibody Drug Coupling Outsourcing Services
- Dual Anticoupling Material Outsourcing Services
- Antibody Oligonucleotide Coupling Outsourcing Services
- Others
Segment by Application
- Tumor Treatment
- Autoimmune Disease Treatment
- Treatment of Metabolic Disorders
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Bio-coupling Drug Outsourcing Services in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Bio-coupling Drug Outsourcing Services manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-coupling Drug Outsourcing Services revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Drug Coupling Outsourcing Services
1.2.3 Dual Anticoupling Material Outsourcing Services
1.2.4 Antibody Oligonucleotide Coupling Outsourcing Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Tumor Treatment
1.3.3 Autoimmune Disease Treatment
1.3.4 Treatment of Metabolic Disorders
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-coupling Drug Outsourcing Services Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Region (2020-2025)
2.4 Global Bio-coupling Drug Outsourcing Services Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Bio-coupling Drug Outsourcing Services Market Size and Prospective (2020-2031)
2.5.2 Europe Bio-coupling Drug Outsourcing Services Market Size and Prospective (2020-2031)
2.5.3 China Bio-coupling Drug Outsourcing Services Market Size and Prospective (2020-2031)
2.5.4 South Korea Bio-coupling Drug Outsourcing Services Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Bio-coupling Drug Outsourcing Services Historic Market Size by Type (2020-2025)
3.2 Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Type (2026-2031)
3.3 Different Types Bio-coupling Drug Outsourcing Services Representative Players
4 Breakdown Data by Application
4.1 Global Bio-coupling Drug Outsourcing Services Historic Market Size by Application (2020-2025)
4.2 Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Bio-coupling Drug Outsourcing Services Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Bio-coupling Drug Outsourcing Services Players by Revenue (2020-2025)
5.1.2 Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Bio-coupling Drug Outsourcing Services Revenue
5.4 Global Bio-coupling Drug Outsourcing Services Market Concentration Analysis
5.4.1 Global Bio-coupling Drug Outsourcing Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Bio-coupling Drug Outsourcing Services Revenue in 2024
5.5 Global Key Players of Bio-coupling Drug Outsourcing Services Head office and Area Served
5.6 Global Key Players of Bio-coupling Drug Outsourcing Services, Product and Application
5.7 Global Key Players of Bio-coupling Drug Outsourcing Services, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025)
6.1.2.2 North America Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025)
6.1.3.2 North America Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025)
6.2.2.2 Europe Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025)
6.2.3.2 Europe Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025)
6.3.2.2 China Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025)
6.3.3.2 China Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 South Korea Market: Players, Segments and Downstream
6.4.1 South Korea Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025)
6.4.2 South Korea Market Size by Type
6.4.2.1 South Korea Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025)
6.4.2.2 South Korea Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
6.4.3 South Korea Market Size by Application
6.4.3.1 South Korea Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025)
6.4.3.2 South Korea Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
6.4.4 South Korea Market Trend and Opportunities
7 Key Players Profiles
7.1 Lonza
7.1.1 Lonza Company Details
7.1.2 Lonza Business Overview
7.1.3 Lonza Bio-coupling Drug Outsourcing Services Introduction
7.1.4 Lonza Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.1.5 Lonza Recent Development
7.2 BSP Pharmaceuticals
7.2.1 BSP Pharmaceuticals Company Details
7.2.2 BSP Pharmaceuticals Business Overview
7.2.3 BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Introduction
7.2.4 BSP Pharmaceuticals Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.2.5 BSP Pharmaceuticals Recent Development
7.3 Catalent
7.3.1 Catalent Company Details
7.3.2 Catalent Business Overview
7.3.3 Catalent Bio-coupling Drug Outsourcing Services Introduction
7.3.4 Catalent Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.3.5 Catalent Recent Development
7.4 Merck
7.4.1 Merck Company Details
7.4.2 Merck Business Overview
7.4.3 Merck Bio-coupling Drug Outsourcing Services Introduction
7.4.4 Merck Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.4.5 Merck Recent Development
7.5 WuXi XDC Cayman Inc
7.5.1 WuXi XDC Cayman Inc Company Details
7.5.2 WuXi XDC Cayman Inc Business Overview
7.5.3 WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Introduction
7.5.4 WuXi XDC Cayman Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.5.5 WuXi XDC Cayman Inc Recent Development
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Company Details
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Introduction
7.6.4 Thermo Fisher Scientific Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.6.5 Thermo Fisher Scientific Recent Development
7.7 Samsung Biologics
7.7.1 Samsung Biologics Company Details
7.7.2 Samsung Biologics Business Overview
7.7.3 Samsung Biologics Bio-coupling Drug Outsourcing Services Introduction
7.7.4 Samsung Biologics Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.7.5 Samsung Biologics Recent Development
7.8 Recipharm
7.8.1 Recipharm Company Details
7.8.2 Recipharm Business Overview
7.8.3 Recipharm Bio-coupling Drug Outsourcing Services Introduction
7.8.4 Recipharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.8.5 Recipharm Recent Development
7.9 Axplora
7.9.1 Axplora Company Details
7.9.2 Axplora Business Overview
7.9.3 Axplora Bio-coupling Drug Outsourcing Services Introduction
7.9.4 Axplora Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.9.5 Axplora Recent Development
7.10 Sterling Pharmaceuticals、
7.10.1 Sterling Pharmaceuticals、 Company Details
7.10.2 Sterling Pharmaceuticals、 Business Overview
7.10.3 Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Introduction
7.10.4 Sterling Pharmaceuticals、 Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.10.5 Sterling Pharmaceuticals、 Recent Development
7.11 NJ Bio, Inc
7.11.1 NJ Bio, Inc Company Details
7.11.2 NJ Bio, Inc Business Overview
7.11.3 NJ Bio, Inc Bio-coupling Drug Outsourcing Services Introduction
7.11.4 NJ Bio, Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.11.5 NJ Bio, Inc Recent Development
7.12 Piramal Grangemouth
7.12.1 Piramal Grangemouth Company Details
7.12.2 Piramal Grangemouth Business Overview
7.12.3 Piramal Grangemouth Bio-coupling Drug Outsourcing Services Introduction
7.12.4 Piramal Grangemouth Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.12.5 Piramal Grangemouth Recent Development
7.13 Abzena
7.13.1 Abzena Company Details
7.13.2 Abzena Business Overview
7.13.3 Abzena Bio-coupling Drug Outsourcing Services Introduction
7.13.4 Abzena Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.13.5 Abzena Recent Development
7.14 Fleet Bioprocessing
7.14.1 Fleet Bioprocessing Company Details
7.14.2 Fleet Bioprocessing Business Overview
7.14.3 Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Introduction
7.14.4 Fleet Bioprocessing Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.14.5 Fleet Bioprocessing Recent Development
7.15 MabPlex international
7.15.1 MabPlex international Company Details
7.15.2 MabPlex international Business Overview
7.15.3 MabPlex international Bio-coupling Drug Outsourcing Services Introduction
7.15.4 MabPlex international Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.15.5 MabPlex international Recent Development
7.16 Toyo Pharm
7.16.1 Toyo Pharm Company Details
7.16.2 Toyo Pharm Business Overview
7.16.3 Toyo Pharm Bio-coupling Drug Outsourcing Services Introduction
7.16.4 Toyo Pharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.16.5 Toyo Pharm Recent Development
7.17 Aobak
7.17.1 Aobak Company Details
7.17.2 Aobak Business Overview
7.17.3 Aobak Bio-coupling Drug Outsourcing Services Introduction
7.17.4 Aobak Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.17.5 Aobak Recent Development
7.18 Asymchem
7.18.1 Asymchem Company Details
7.18.2 Asymchem Business Overview
7.18.3 Asymchem Bio-coupling Drug Outsourcing Services Introduction
7.18.4 Asymchem Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.18.5 Asymchem Recent Development
7.19 Porton Pharma Solutions
7.19.1 Porton Pharma Solutions Company Details
7.19.2 Porton Pharma Solutions Business Overview
7.19.3 Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Introduction
7.19.4 Porton Pharma Solutions Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
7.19.5 Porton Pharma Solutions Recent Development
8 Bio-coupling Drug Outsourcing Services Market Dynamics
8.1 Bio-coupling Drug Outsourcing Services Industry Trends
8.2 Bio-coupling Drug Outsourcing Services Market Drivers
8.3 Bio-coupling Drug Outsourcing Services Market Challenges
8.4 Bio-coupling Drug Outsourcing Services Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Bio-coupling Drug Outsourcing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Bio-coupling Drug Outsourcing Services Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Bio-coupling Drug Outsourcing Services Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Bio-coupling Drug Outsourcing Services Revenue Share by Region (2020-2025)
Table 6. Global Bio-coupling Drug Outsourcing Services Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Bio-coupling Drug Outsourcing Services Revenue Share Forecast by Region (2026-2031)
Table 8. Global Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Type (2020-2025)
Table 10. Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Application (2020-2025)
Table 15. Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Bio-coupling Drug Outsourcing Services Application
Table 18. Global Bio-coupling Drug Outsourcing Services Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Bio-coupling Drug Outsourcing Services Market Share by Players (2020-2025)
Table 20. Global Top Bio-coupling Drug Outsourcing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-coupling Drug Outsourcing Services as of 2024)
Table 21. Ranking of Global Top Bio-coupling Drug Outsourcing Services Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Bio-coupling Drug Outsourcing Services Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Bio-coupling Drug Outsourcing Services, Headquarters and Area Served
Table 24. Global Key Players of Bio-coupling Drug Outsourcing Services, Product and Application
Table 25. Global Key Players of Bio-coupling Drug Outsourcing Services, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Bio-coupling Drug Outsourcing Services Revenue Market Share by Company (2020-2025)
Table 29. North America Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Bio-coupling Drug Outsourcing Services Revenue Market Share by Company (2020-2025)
Table 33. Europe Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Bio-coupling Drug Outsourcing Services Revenue Market Share by Company (2020-2025)
Table 37. China Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025) & (US$ Million)
Table 39. South Korea Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025) & (US$ Million)
Table 40. South Korea Bio-coupling Drug Outsourcing Services Revenue Market Share by Company (2020-2025)
Table 41. South Korea Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025) & (US$ Million)
Table 42. South Korea Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025) & (US$ Million)
Table 43. Lonza Company Details
Table 44. Lonza Business Overview
Table 45. Lonza Bio-coupling Drug Outsourcing Services Product
Table 46. Lonza Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 47. Lonza Recent Development
Table 48. BSP Pharmaceuticals Company Details
Table 49. BSP Pharmaceuticals Business Overview
Table 50. BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Product
Table 51. BSP Pharmaceuticals Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 52. BSP Pharmaceuticals Recent Development
Table 53. Catalent Company Details
Table 54. Catalent Business Overview
Table 55. Catalent Bio-coupling Drug Outsourcing Services Product
Table 56. Catalent Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 57. Catalent Recent Development
Table 58. Merck Company Details
Table 59. Merck Business Overview
Table 60. Merck Bio-coupling Drug Outsourcing Services Product
Table 61. Merck Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 62. Merck Recent Development
Table 63. WuXi XDC Cayman Inc Company Details
Table 64. WuXi XDC Cayman Inc Business Overview
Table 65. WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Product
Table 66. WuXi XDC Cayman Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 67. WuXi XDC Cayman Inc Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Product
Table 71. Thermo Fisher Scientific Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Samsung Biologics Company Details
Table 74. Samsung Biologics Business Overview
Table 75. Samsung Biologics Bio-coupling Drug Outsourcing Services Product
Table 76. Samsung Biologics Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 77. Samsung Biologics Recent Development
Table 78. Recipharm Company Details
Table 79. Recipharm Business Overview
Table 80. Recipharm Bio-coupling Drug Outsourcing Services Product
Table 81. Recipharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 82. Recipharm Recent Development
Table 83. Axplora Company Details
Table 84. Axplora Business Overview
Table 85. Axplora Bio-coupling Drug Outsourcing Services Product
Table 86. Axplora Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 87. Axplora Recent Development
Table 88. Sterling Pharmaceuticals、 Company Details
Table 89. Sterling Pharmaceuticals、 Business Overview
Table 90. Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Product
Table 91. Sterling Pharmaceuticals、 Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 92. Sterling Pharmaceuticals、 Recent Development
Table 93. NJ Bio, Inc Company Details
Table 94. NJ Bio, Inc Business Overview
Table 95. NJ Bio, Inc Bio-coupling Drug Outsourcing Services Product
Table 96. NJ Bio, Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 97. NJ Bio, Inc Recent Development
Table 98. Piramal Grangemouth Company Details
Table 99. Piramal Grangemouth Business Overview
Table 100. Piramal Grangemouth Bio-coupling Drug Outsourcing Services Product
Table 101. Piramal Grangemouth Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 102. Piramal Grangemouth Recent Development
Table 103. Abzena Company Details
Table 104. Abzena Business Overview
Table 105. Abzena Bio-coupling Drug Outsourcing Services Product
Table 106. Abzena Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 107. Abzena Recent Development
Table 108. Fleet Bioprocessing Company Details
Table 109. Fleet Bioprocessing Business Overview
Table 110. Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Product
Table 111. Fleet Bioprocessing Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 112. Fleet Bioprocessing Recent Development
Table 113. MabPlex international Company Details
Table 114. MabPlex international Business Overview
Table 115. MabPlex international Bio-coupling Drug Outsourcing Services Product
Table 116. MabPlex international Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 117. MabPlex international Recent Development
Table 118. Toyo Pharm Company Details
Table 119. Toyo Pharm Business Overview
Table 120. Toyo Pharm Bio-coupling Drug Outsourcing Services Product
Table 121. Toyo Pharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 122. Toyo Pharm Recent Development
Table 123. Aobak Company Details
Table 124. Aobak Business Overview
Table 125. Aobak Bio-coupling Drug Outsourcing Services Product
Table 126. Aobak Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 127. Aobak Recent Development
Table 128. Asymchem Company Details
Table 129. Asymchem Business Overview
Table 130. Asymchem Bio-coupling Drug Outsourcing Services Product
Table 131. Asymchem Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 132. Asymchem Recent Development
Table 133. Porton Pharma Solutions Company Details
Table 134. Porton Pharma Solutions Business Overview
Table 135. Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Product
Table 136. Porton Pharma Solutions Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
Table 137. Porton Pharma Solutions Recent Development
Table 138. Bio-coupling Drug Outsourcing Services Market Trends
Table 139. Bio-coupling Drug Outsourcing Services Market Drivers
Table 140. Bio-coupling Drug Outsourcing Services Market Challenges
Table 141. Bio-coupling Drug Outsourcing Services Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-coupling Drug Outsourcing Services Product Picture
Figure 2. Global Bio-coupling Drug Outsourcing Services Market Share by Type: 2024 VS 2031
Figure 3. Antibody Drug Coupling Outsourcing Services Features
Figure 4. Dual Anticoupling Material Outsourcing Services Features
Figure 5. Antibody Oligonucleotide Coupling Outsourcing Services Features
Figure 6. Others Features
Figure 7. Global Bio-coupling Drug Outsourcing Services Market Share by Application: 2024 VS 2031
Figure 8. Tumor Treatment
Figure 9. Autoimmune Disease Treatment
Figure 10. Treatment of Metabolic Disorders
Figure 11. Others
Figure 12. Bio-coupling Drug Outsourcing Services Report Years Considered
Figure 13. Global Bio-coupling Drug Outsourcing Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Bio-coupling Drug Outsourcing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Bio-coupling Drug Outsourcing Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Bio-coupling Drug Outsourcing Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Bio-coupling Drug Outsourcing Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. South Korea Bio-coupling Drug Outsourcing Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Bio-coupling Drug Outsourcing Services Market Share by Players in 2024
Figure 21. Global Top Bio-coupling Drug Outsourcing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-coupling Drug Outsourcing Services as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Bio-coupling Drug Outsourcing Services Revenue in 2024
Figure 23. North America Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
Figure 24. North America Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
Figure 25. Europe Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
Figure 26. Europe Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
Figure 27. China Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
Figure 28. China Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
Figure 29. South Korea Bio-coupling Drug Outsourcing Services Market Share by Type (2020-2025)
Figure 30. South Korea Bio-coupling Drug Outsourcing Services Market Share by Application (2020-2025)
Figure 31. Lonza Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 32. BSP Pharmaceuticals Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 33. Catalent Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 34. Merck Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 35. WuXi XDC Cayman Inc Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 36. Thermo Fisher Scientific Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 37. Samsung Biologics Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 38. Recipharm Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 39. Axplora Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 40. Sterling Pharmaceuticals、 Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 41. NJ Bio, Inc Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 42. Piramal Grangemouth Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 43. Abzena Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 44. Fleet Bioprocessing Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 45. MabPlex international Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 46. Toyo Pharm Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 47. Aobak Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 48. Asymchem Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 49. Porton Pharma Solutions Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Bio-coupling Drug Outsourcing Services market size from 2025 to 2031?
The annual compound growth rate of the global Bio-coupling Drug Outsourcing Services market is 18.4% 2025 to 2031.
Which region is expected to have the highest market share?
What was the global market size of Bio-coupling Drug Outsourcing Services in 2025?
Which companies rank high in the global Bio-coupling Drug Outsourcing Services market?
What was the global market size of Bio-coupling Drug Outsourcing Services in 2031?
Related Reports
Global Bio-coupling Drug Outsourcing Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bio-coupling Drug Outsourcing Services market is projected to grow from US$ 3167 million in 2025 to US$ 10170 million by 2032, at a CAGR of 18.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 158
USD 4900.00
(Single User License)
Global Bio-coupling Drug Outsourcing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bio-coupling Drug Outsourcing Services market size was US$ 3167 million in 2025 and is forecast to reach a readjusted size of US$ 10170 million by 2032 with a CAGR of 18.4% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 101
USD 4250.00
(Single User License)
Global Bio-coupling Drug Outsourcing Services Market Research Report 2026
The global Bio-coupling Drug Outsourcing Services market was valued at US$ 3167 million in 2025 and is anticipated to reach US$ 10170 million by 2032, at a CAGR of 18.4% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 129
USD 2900.00
(Single User License)
Bio-coupling Drug Outsourcing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-coupling Drug Outsourcing Services was estimated to be worth US$ 3167 million in 2025 and is projected to reach US$ 10170 million, growing at a CAGR of 18.4% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 3950.00
(Single User License)
Global Bio-coupling Drug Outsourcing Services Market Research Report 2025
The global market for Bio-coupling Drug Outsourcing Services was valued at US$ 2675 million in the year 2024 and is projected to reach a revised size of US$ 8725 million by 2031, growing at a CAGR of 18.4% during the forecast period.
Published Date: 2025-02-09
Pages: 95
USD 2900.00
(Single User License)
Bio-coupling Drug Outsourcing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-coupling Drug Outsourcing Services was estimated to be worth US$ 2675 million in 2024 and is forecast to a readjusted size of US$ 8725 million by 2031 with a CAGR of 18.4% during the forecast period 2025-2031.
Published Date: 2025-02-09
Pages: 126
USD 3950.00
(Single User License)
Global Bio-coupling Drug Outsourcing Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bio-coupling Drug Outsourcing Services market is projected to grow from US$ 3167 million in 2025 to US$ 10170 million by 2032, at a CAGR of 18.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 158
USD 4900.00 (Single User License)Global Bio-coupling Drug Outsourcing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bio-coupling Drug Outsourcing Services market size was US$ 3167 million in 2025 and is forecast to reach a readjusted size of US$ 10170 million by 2032 with a CAGR of 18.4% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 101
USD 4250.00 (Single User License)Global Bio-coupling Drug Outsourcing Services Market Research Report 2026
The global Bio-coupling Drug Outsourcing Services market was valued at US$ 3167 million in 2025 and is anticipated to reach US$ 10170 million by 2032, at a CAGR of 18.4% from 2026 to 2032.
Published: 2026-03-11
Pages: 129
USD 2900.00 (Single User License)Bio-coupling Drug Outsourcing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-coupling Drug Outsourcing Services was estimated to be worth US$ 3167 million in 2025 and is projected to reach US$ 10170 million, growing at a CAGR of 18.4% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 3950.00 (Single User License)Global Bio-coupling Drug Outsourcing Services Market Research Report 2025
The global market for Bio-coupling Drug Outsourcing Services was valued at US$ 2675 million in the year 2024 and is projected to reach a revised size of US$ 8725 million by 2031, growing at a CAGR of 18.4% during the forecast period.
Published: 2025-02-09
Pages: 95
USD 2900.00 (Single User License)Bio-coupling Drug Outsourcing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-coupling Drug Outsourcing Services was estimated to be worth US$ 2675 million in 2024 and is forecast to a readjusted size of US$ 8725 million by 2031 with a CAGR of 18.4% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 126
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now